Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study
By J. Davila, R. Morgan, Y. Shaib, K. McGlynn, H. B. EL‐SERAG. Gut, 2005
705 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Epidemiology, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/70d91a84351299e128e5de604b5f6149adc1c1c0
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
Citations in the corpus
- The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis (2010, background): “Several studies have examined the association between diabetes and HCC with conflicting results.(27,29) In fact, these studies failed to identify whether diabetes precedes the development of underlying liver disease or HCC.”
- Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. (2012, background): “A population-based study from 14% of the United States population found that diabetes conferred a three-fold risk of HCC [12].”
- Sustained Virologic Response and Clinical Outcomes in Patients with Chronic Hepatitis C and Advanced Fibrosis (2007, background): “Both of these factors have been suggested to increase the risk for HCC (21), although the effect of anti–hepatitis B core antigen positivity on development of HCC remains controversial (22– 24).”
- iArc monogrAphs on the evAluAtion oF cArcinogenic risks to humAns (2012, background): “(a) Combined analysis of North American case– control studies The combined analysis of seven North American case–control studies included a total of 3662 cases and 4966 controls (Krewski et al., 2005, 2006).”
- Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. (2008, background): “The significant association between diabetes and HCC was independent of HBV infection in the only study that examined this factor [142].”
- The interaction of hepatic lipid and glucose metabolism in liver diseases. (2012, neutral): “3A) [118,119].”